Percheron Therapeutics Limited Share Price
Equities
PER
AU0000317281
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.068 AUD | +6.25% | -6.85% | +15.25% |
28/02 | Percheron Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
2023 | Dimerix Appoints Nonexecutive Chair | MT |
Sales 2024 * | 3.56M 2.33M 194M | Sales 2025 * | 5.25M 3.43M 286M | Capitalization | 61.31M 40.04M 3.34B |
---|---|---|---|---|---|
Net income 2024 * | -17M -11.1M -926M | Net income 2025 * | -31M -20.25M -1.69B | EV / Sales 2024 * | 15.5 x |
Net cash position 2024 * | 6.1M 3.98M 332M | Net cash position 2025 * | 17.41M 11.37M 948M | EV / Sales 2025 * | 8.36 x |
P/E ratio 2024 * |
-3.58
x | P/E ratio 2025 * |
-1.61
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.66% |
1 day | +6.25% | ||
1 week | -6.85% | ||
Current month | -18.07% | ||
1 month | -21.84% | ||
3 months | +17.24% | ||
6 months | +15.25% | ||
Current year | +15.25% |
Managers | Title | Age | Since |
---|---|---|---|
James Garner
CEO | Chief Executive Officer | - | 08/23/08 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 09/06/09 |
Anthony Filippis
COO | Chief Operating Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Hains
DFI | Director of Finance/CFO | 64 | 09/06/09 |
Ben Price
BRD | Director/Board Member | 68 | 04/21/04 |
James Garner
CEO | Chief Executive Officer | - | 08/23/08 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.068 | +6.25% | 2,885,250 |
24/24/24 | 0.064 | -13.51% | 8,992,853 |
23/24/23 | 0.074 | -2.63% | 885,246 |
22/24/22 | 0.076 | +4.11% | 117,881 |
19/24/19 | 0.073 | -3.95% | 711,375 |
End-of-day quote Australian S.E., April 26, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.25% | 39.98M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PER Stock